Get Real Time Here
| Open- | Close- |
| Vol / Avg.31.000 / 310.509K | Mkt Cap33.312M |
| Day Range- - - | 52 Wk Range0.458 - 1.760 |
Homology Medicines Stock (NASDAQ:FIXX), Quotes and News Summary
Homology Medicines Stock (NASDAQ: FIXX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.31.000 / 310.509K | Mkt Cap33.312M |
| Day Range- - - | 52 Wk Range0.458 - 1.760 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.420 | -0.570 | -0.1500 | ||||
| REV | 500.000K | 0 | -500.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-28 | Baird | Madhu Kumar | Downgrades | OutperformNeutral | Lowers | 9.00 | 1.50 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-12 | Credit Suisse | Richard Law | Reiterates | NeutralNeutral | Maintains | - | 2.00 |
| 2023-05-12 | Chardan Capital | Matthew Barcus | Maintains | BuyBuy | Lowers | 8.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| FIXX | Homology Medicines | 3.27% | 33.3M |
| CLRB | Cellectar Biosciences | 1.13% | 32.9M |
| PHXM | PHAXIAM Therapeutics | 9.37% | 29.8M |
| COEP | Coeptis Therapeutics | 1.91% | 36.2M |
| BOLT | Bolt Biotherapeutics | 0% | 34.2M |
How do I buy Homology Medicines (FIXX) stock?
You can purchase shares of Homology Medicines (NASDAQ: FIXX) through any online brokerage.
Who are Homology Medicines's (FIXX) competitors?
Other companies in Homology Medicines’s space includes: Cellectar Biosciences (NASDAQ:CLRB), PHAXIAM Therapeutics (NASDAQ:PHXM), Coeptis Therapeutics (NASDAQ:COEP), Bolt Biotherapeutics (NASDAQ:BOLT) and Eledon Pharma (NASDAQ:ELDN).
What is the target price for Homology Medicines (FIXX) stock?
The latest price target for Homology Medicines (NASDAQ: FIXX) was reported by Baird on Friday, July 28, 2023. The analyst firm set a price target for 1.50 expecting FIXX to rise to within 12 months (a possible 160.87% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Homology Medicines (FIXX)?
The stock price for Homology Medicines (NASDAQ: FIXX) is $0.575 last updated December 8, 2023 at 12:23 PM UTC.
Does Homology Medicines (FIXX) pay a dividend?
There is no dividend information for Homology Medicines.
When is Homology Medicines (NASDAQ:FIXX) reporting earnings?
Homology Medicines’s Q4 earnings are confirmed for Thursday, March 7, 2024.
Is Homology Medicines (FIXX) going to split?
There is no upcoming split for Homology Medicines.
What sector and industry does Homology Medicines (FIXX) operate in?
Homology Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.